Literature DB >> 35402990

A 25-Year-Old Chronic Ketamine User with Urinary Symptoms; a Case Report.

Chin-Chu Wu1, Aming Chor-Ming Lin2,3.   

Abstract

Ketamine is mainly used for short-acting general anesthesia, chronic pain, sedation, depression, and bipolar disorder. Long-term ketamine use may cause lower urinary tract symptoms and voiding dysfunction. Small capacity and fibrotic bladder can be associated with chronic ketamine use. Here, we present a 25-year-old male with a history of chronic ketamine use complicated with contracted heart-shape bladder.

Entities:  

Keywords:  Ketamine; Tomography; Urinary Tract Infections; Urologic Diseases; X-Ray Computed

Year:  2022        PMID: 35402990      PMCID: PMC8986501          DOI: 10.22037/aaem.v10i1.1449

Source DB:  PubMed          Journal:  Arch Acad Emerg Med        ISSN: 2645-4904


1. Introduction:

Sustained ketamine use results in small capacity, and fibrotic and contracted bladder, which can lead to damage to the urinary tract system. The clinical presentations range from suprapubic pain, small volume voids, and irritative lower tract symptoms to painful hematuria. Long-term abusers with a small and fibrotic bladder and poor compliance are at high risk for complications including hydronephrosis, vesicoureteral reflux, urolithiasis, chronic renal failure, and recurrent urinary tract infections (1). We herein report a case of chronic ketamine use, complicated with contracted bladder with a heart-shape appearance on computed tomography (CT) scan.

2. Case presentation:

A 25-year-old man presented to the emergency department with complaint of fever, urinary frequency, dysuria, bilateral dull flank pain, and unspecific abdominal pain for one week. He had a history of bipolar disorder and chronic ketamine use. On arrival, his blood pressure was 138/82 mmHg, with a heart rate of 101 beats/minute, a respiratory rate of 20 beats/minute, and oxygen saturation of 98% on room air. His temperature was 38.2 °C. On physical examination, the patient had lower abdominal tenderness and bilateral flank knocking pain. The rest of physical examination were unremarkable. The complete blood cell count showed the following results: leukocyte count 14500/mm3 with 92% of segmented neutrophils, hemoglobin 10.8 gram/deciliter, platelet 520000/microliter, and an international normalized ratio (INR) of 0.8. Urinalysis showed severe pyuria and gross hematuria. Other laboratory findings included: glucose 100 milligram/deciliter, blood urea nitrogen (BUN) 38 mg/dl, serum creatinine 2.6 mg/dl, sodium 135 mEq/L, potassium 4.1 mEq/L, and serum glutamic oxaloacetic transaminase (SGOT) 48 U/L. The patient underwent abdominopelvic computed tomography (CT) scan without contrast material due to renal insufficiency. Axial view of abdominopelvic CT scan showed thick-wall bladder with pseudo-diverticula, dilatation of bilateral proximal ureter, and left hydronephrosis (figure 1). Coronal view of CT scan showed a contracted heart-shape bladder (figure 1). A diagnosis of ketamine-associated uropathy, complicated with urinary tract infection, was made. The patient was started on intravenous fluids, parenteral antibiotics, and continuous urinary drainage through a Foley. On the following days, urine and blood cultures yielded Escherichia coli. He recovered with conservative management and was discharged 12 days later.
Figure 1

Axial (left) and coronal (right) views of the patient’s abdominopelvic computed tomography scan

3. Discussion:

Ketamine is a non-competitive N-methyl-D-aspartate receptor antagonist medication, mainly used for short-acting general anesthesia, chronic pain, sedation, depression, and bipolar disorder (2). Ketamine is also used as a recreational drug due to its hallucinogenic and dissociative effects. Because of its low price and easy usage, use of ketamine as a recreational drug is being increasingly reported worldwide. Long-term ketamine abuse may cause severe lower urinary tract symptoms and voiding dysfunction. Chronic ketamine use can damage many organs including the brain, heart, liver, gastrointestinal tract, and genitourinary system (3). Urinary tract abnormalities are the most commonly reported undesirable chronic effects related to ketamine abuse (4, 5). Chronic ketamine abuse may be associated with ulcerative cystitis, urge incontinence, decreased bladder volume, decreased bladder compliance, detrusor overactivity, and painful hematuria (6). Secondary renal damage can occur in long-term abusers (7, 8). Lower urinary tract symptoms may be associated with chronic urinary infection and ketamine-associated ulcerative cystitis. Cessation of ketamine use and proper treatment may improve most lower urinary tract symptoms. Axial (left) and coronal (right) views of the patient’s abdominopelvic computed tomography scan

4. Conclusion:

Patients with a history of chronic ketamine use with persistent lower tract symptoms need to be encouraged to immediately cease its use and refer to a urologist for assessment. Contracted bladder patients with frequent recurrent urinary tract infection should be investigated. CT is useful in detecting the causes of urinary symptoms, such as calculi, bladder debris, bladder fibrosis, and poor bladder compliance, as well as in early diagnosis of ketamine-associated uropathy.

5. Declarations:

5.1 Acknowledgements

We acknowledge all the staff of department of diagnostic radiology and emergency department of Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan.

5.2 Conflict of interest

None

5.3 Funding and support

None

5.4 Authors’ contributions

All authors passed four criteria for authorship contribution based on recommendations of the Internal Committee of Medical Journal Editors.
  7 in total

Review 1.  Lower urinary tract destruction due to ketamine: a report of 4 cases and review of literature.

Authors:  Song Wu; Yongqin Lai; Yingying He; Xianxin Li; Zhichen Guan; Zhiming Cai
Journal:  J Addict Med       Date:  2012-03       Impact factor: 3.702

2.  Ketamine-associated lower urinary tract destruction: a new radiological challenge.

Authors:  K Mason; A M Cottrell; A G Corrigan; D A Gillatt; A E Mitchelmore
Journal:  Clin Radiol       Date:  2010-07-29       Impact factor: 2.350

Review 3.  Emergency department presentation of ketamine abusers in Hong Kong: a review of 233 cases.

Authors:  S H Ng; M L Tse; H W Ng; F L Lau
Journal:  Hong Kong Med J       Date:  2010-02       Impact factor: 2.227

4.  The destruction of the lower urinary tract by ketamine abuse: a new syndrome?

Authors:  Peggy Sau-Kwan Chu; Wai-Kit Ma; Simon Chun-Wing Wong; Ringo Wing-Hong Chu; Cheung-Hing Cheng; Shun Wong; Johnny Man-Li Tse; Fei-Lung Lau; Ming-Kwong Yiu; Chi-Wai Man
Journal:  BJU Int       Date:  2008-08-01       Impact factor: 5.588

5.  The clinical presentation and diagnosis of ketamine-associated urinary tract dysfunction in Singapore.

Authors:  Jacklyn Yek; Palaniappan Sundaram; Hakan Aydin; Tricia Kuo; Lay Guat Ng
Journal:  Singapore Med J       Date:  2015-12       Impact factor: 1.858

Review 6.  Management of complications of ketamine abuse: 10 years' experience in Hong Kong.

Authors:  Y L Hong; C H Yee; Y H Tam; J Hm Wong; P T Lai; C F Ng
Journal:  Hong Kong Med J       Date:  2018-04-06       Impact factor: 2.227

7.  Ketamine for the treatment of major depressive disorder and bipolar depression: A review of the literature.

Authors:  Sarah E Grady; Travis A Marsh; Allison Tenhouse; Kelsey Klein
Journal:  Ment Health Clin       Date:  2018-03-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.